Reinvent Pharma
Immune-based Anticancer Technologies
Health Tech & Life Sciences
Non Active, Feb 2026 ceased to operate
Company Overview
Snapshot
Founded in November 2010 by Itschak Lamensdorf, Reinvent Pharma operated with 1–10 employees. The company ceased operations in February 2026.
Business overview
Reinvent Pharma is a patient-oriented company focused on developing therapeutics for immune and targeted therapies. The company's core technology involves combining approved drugs to enhance clinical outcomes, with an initial focus on solid tumors such as pancreatic, liver, bile duct, and brain tumors. Operating within the Health Tech & Life Sciences sector, Reinvent Pharma serves the pharmaceutical industry with its drug discovery and development efforts.
Company Intelligence Q&A
- What is Reinvent Pharma's primary focus?
- Reinvent Pharma focuses on developing immune-based anticancer technologies, specifically therapeutics that combine approved drugs to improve the clinical outcome of immune and targeted therapies.
- When was Reinvent Pharma founded?
- Reinvent Pharma was founded in November 2010.
- Who founded Reinvent Pharma?
- Itschak Lamensdorf is the Founder & CEO of Reinvent Pharma.
- What types of tumors does Reinvent Pharma initially target?
- Reinvent Pharma's initial main field of interest is a selected niche of targeted solid tumors, including pancreatic, liver, bile duct, and brain tumors.
- What is the operational status of Reinvent Pharma?
- Reinvent Pharma ceased to operate in February 2026.